| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0202 |
| Document Type: 4 |
| Period of Report: 8/15/05 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1088856 |
| Issuer Name: CORCEPT THERAPEUTICS INC |
| Issuer Trading Symbol: CORT |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1286029 |
| | Owner Name: SCHATZBERG ALAN F |
| Reporting Owner Address: |
| | Owner Street 1: C/O CORCEPT THERAPEUTICS |
| | Owner Street 2: 149 COMMONWEALTH DRIVE |
| | Owner City: MENLO PARK |
| | Owner State: CA |
| | Owner ZIP Code: 94025 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? No |
| | Is Ten Percent Owner? Yes |
| | Is Other? No |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 8/15/05 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: S |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 15,597 |
| | | Transaction Price Per Share: |
| Value: 7.00 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 2,388,749 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Non-Derivative Holding: |
| | Security Title: |
| | | Value: Common Stock |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 300,000 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: I |
| | | Nature of Ownership: |
| Value: held by daughter #1 |
| Footnote ID: F2 |
| Footnotes: |
| Footnote - F1: The sale on this Form 4 was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 27, 2004. |
| Footnote - F2: The Reporting Person has voting control of the shares and disclaims beneficial ownership of the shares. |
| Remarks: The Reporting Person no longer has a reportable beneficial interest in 300,000 shares of CORT common stock owned by daughter #2 which was included in the Reporting Person's prior ownership reports. |
| Owner Signature: |
| Signature Name: s/s Fred Kurland, CFO of Corcept Therapeutics Incorporated attorney-in-fact |
| Signature Date: 8/16/05 |
